INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Option exerciseVerified dataRule 10b5-1 plan

Olivo Alicia C reported NEO

EVP, GC & Business Development · NEOGENOMICS INC · NEOGENOMICS INC — Stock Option (Right to Buy)

Side
M
Value
—
Shares
8,977
Price
—
Executed
Nov 25, 2025
Disclosed
Nov 28, 2025
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Nov 25 executedNov 28, 2025 disclosed

NEO · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
13/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+9 / 25

No reported dollar value · 24.0% of prior position

  • Filing timing+6 / 15

    Disclosed 3 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · NEO

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    28
    Gilbert Ray Cisneros, Jr.DSelf
    NEONEOGENOMICS INC
    Purchase
    		BUY$1,001 – $15KAug 7, 2026Sep 10, 2026
    traded Aug 7, 2026
    		+34dHOUSE PTR

    Evidence

    21
    SW
    Stone WarrenPres & Chief Operating Officer
    NEONEOGENOMICS INC
    Option exercise
    		M—
    59.4K sh
    		Jan 13, 2026Jan 15, 2026
    traded Jan 13, 2026
    		+2dSEC FORM 4

    Evidence

    17
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Option exercise
    		M—
    59.4K sh
    		Jan 13, 2026Jan 15, 2026
    traded Jan 13, 2026
    		+2dSEC FORM 4

    Evidence

    13
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Tax withholding
    		F—
    15.1K sh
    		Jan 13, 2026Jan 15, 2026
    traded Jan 13, 2026
    		+2dSEC FORM 4

    Evidence

    13
    SW
    Stone WarrenPres & Chief Operating Officer
    NEONEOGENOMICS INC
    Tax withholding
    		F—
    15.1K sh
    		Jan 13, 2026Jan 15, 2026
    traded Jan 13, 2026
    		+2dSEC FORM 4

    Evidence

    25
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Open-market sale · 10b5-1 plan
    		SELL$251K
    20.9K sh
    		Nov 25, 2025Nov 28, 2025
    traded Nov 25, 2025
    		+3dSEC FORM 4

    Evidence

    16
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Option exercise · 10b5-1 plan
    		M$90K
    8,977 sh
    		Nov 25, 2025Nov 28, 2025
    traded Nov 25, 2025
    		+3dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001628280-25-054270
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Nov 25, 2025
    Published
    Nov 28, 2025
    Ingested by INSIDER
    Nov 5, 04:30 UTC
    Last re-read
    Nov 5, 04:30 UTC

    Extracted facts

    Filer
    Olivo Alicia C
    Role
    EVP, GC & Business Development
    Transaction
    Option exerciseAs filed: “M”
    Asset
    NEOGENOMICS INC — Stock Option (Right to Buy)
    Ticker
    NEO
    Shares
    8,977
    Price per share
    $0
    Execution date (reported)
    Nov 25, 2025
    Owned after transaction
    46.4K shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    3

    What this establishes

    Olivo Alicia C filed this Form 4 reporting a option exercise of NEO on Nov 25, 2025. It became public on Nov 28, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    EVP, GC & Business Development
    Olivo Alicia Ccik:0001951869
    Issuer
    NEOGENOMICS INCcik:0001077183

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.